Hospital policies for treatment of acute decompensated heart failure

Annals of Pharmacotherapy

Volumn 41, Issue 4, 2007, Pages 562-567

  Vats, Vikrant ^a   DiDomenico, Robert J ^a   Wojtynek, Jeffrey E ^b   Theobald, John C ^b   Schumock, Glen T ^a,c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Clinical and Contracting Pharmacy Integration   (United States)

^c Consorta Inc ^*  (United States)

Author keywords

Acute decompensated heart failure; Diuretics; Guidelines; Nesiritide

Indexed keywords

BUMETANIDE; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; FUROSEMIDE; GLYCERYL TRINITRATE; MILRINONE; NESIRITIDE; NITROPRUSSIDE SODIUM;

ACUTE HEART FAILURE; ARTICLE; COMMUNITY HOSPITAL; DRUG FORMULARY; EMERGENCY WARD; HOSPITAL PATIENT; HOSPITAL PHARMACY; HOSPITAL POLICY; HUMAN; INTERNET; MAJOR CLINICAL STUDY; OUTPATIENT; PRACTICE GUIDELINE; PRIORITY JOURNAL;

DIURETICS; HEALTH POLICY; HEART FAILURE, CONGESTIVE; HOSPITALS, COMMUNITY; HUMANS; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDES; PHARMACY SERVICE, HOSPITAL; PRACTICE GUIDELINES; QUESTIONNAIRES; UNITED STATES; VASODILATOR AGENTS;

EID: 34247265968     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H664     Document Type: Article

References (17)

1. Congestive heart failure data fact sheet. Bethesda, MD: National Heart, Lung, and Blood Institute, 1996.
2. Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113:e85-151.
3. Aghababian RV. Acutely decompensated heart failure: opportunities to improve care and outcomes in the emergency department. Rev Cardiovasc Med 2002;3(suppl 1):S3-12.
4. Colucci WS, Elkayam U, Horton DP, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med 2000;343:246-53.
5. National Heart, Lung, and Blood Institute. Morbidity and mortality: 2002 chart book on cardiovascular, lung, and blood diseases. Bethesda, MD: National Institutes of Health; 2002.
6. Burger AJ, Horton DP, LeJemtel T, et al. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study. Am Heart J 2002;144:1102-8.
7. Peacock WF, Emerman CL, Group PS. Safety and efficacy of nesiritide in the treatment of decompensated heart failure in observation patients (abstract). J Am Coll Cardiol 2003;41:336A.
8. Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson K. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA 2005;293:1900-5.
9. Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 2005;111:1487-91.
10. Panel of cardiology experts provides recommendations to Scios regarding NATRECOR. www.natrecor.com/pdf/Braunwald_Panel_Release_&_Report.pdf (accessed 2006 May 31).
11. American Hospital Association Guide. Health Forum/AHA. 2006 ed. Chicago, IL: 2006.
12. Adams KF Jr, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005;149:209-16.
13. Fonarow GC, Adams KF Jr, Abraham WT, et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 2005;293:572-80.
14. Krumholz HM, Parent EM, Tu N, et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 1997;157:99-104.
15. Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail 2006;12:e1-2.
16. DiDomenico RJ, Park HY, Southworth MR, et al. Guidelines for acute decompensated heart failure treatment. Ann Pharmacother 2004;38:649-60. Epub 24 Feb 2004. DOI 10.1345/aph.1D481
17. Eyrich HM, DiDomenico RJ, Fontana DR, et al. Treatment guidelines for acute decompensated heart failure associated with improved outcomes (abstract). Pharmacotherapy 2005;25:1439.